Neurostimulation Evidence

Explore the published clinical evidence supporting auricular vagus nerve stimulation for vascular care and pain management.

This section brings together mechanisms of action, peer-reviewed research, clinical summaries and practical insights to support evidence-based clinical decision-making.

Mechanisms of Action

The evidence supporting auricular vagus nerve stimulation continues to grow across vascular medicine, pain management and autonomic neuromodulation. Explore the key areas of research below.

Autonomic Nervous System

Autonomic Modulation

Auricular vagus nerve stimulation activates afferent fibres of the vagus nerve, influencing central autonomic pathways. This helps restore autonomic balance by increasing parasympathetic activity and reducing excessive sympathetic drive.

Blood Flow

Microcirculation & Blood Flow

Activation of vagal pathways promotes vasodilation and may improve microvascular blood flow through autonomic regulation and nitric oxide signalling. Improved perfusion may support tissue viability and healing.

Inflammation

Inflammatory Regulation

The vagus nerve forms part of the cholinergic anti-inflammatory pathway. Stimulation may reduce excessive inflammatory responses by modulating cytokine release.

Pain

Pain Modulation

Neuromodulation influences pain-processing pathways within the central nervous system, helping reduce pain perception while supporting rehabilitation and functional recovery.

Featured Clinical Summaries

The Nerve Supply of the Human Auricle

Clinical Question

Which regions of the external ear are innervated by the auricular branch of the vagus nerve?

Study

Cadaveric anatomical dissection study examining the nerve supply of 28 external ears from 14 human cadavers.

Key Findings

The cymba conchae demonstrated the highest and most consistent vagal innervation.
The concha is the principal target for auricular vagus nerve stimulation.
Most of the remaining auricle is supplied by other sensory nerves.
The findings provide the anatomical basis for accurate electrode placement.

Clinical Relevance

Understanding the anatomy of the auricular branch of the vagus nerve is fundamental to the safe and effective use of auricular neurostimulation. This anatomical study provides the scientific basis for accurate electrode placement and explains why stimulation at specific regions of the external ear can influence autonomic function and support therapeutic outcomes.

View Published Paper

Auricular Electroacupuncture Reduces Frequency and Severity of Raynaud Attacks

Clinical Question

Can auricular electrical stimulation reduce the frequency and severity of attacks in patients with primary Raynaud's phenomenon?

Study

A prospective clinical study involving 26 patients with primary Raynaud's phenomenon. Participants received six weekly treatment cycles of auricular electrical stimulation and were followed for up to 24 weeks to assess symptom severity and frequency.

Key Findings

Significant reduction in the frequency of Raynaud attacks after 3 and 6 weeks of treatment.
Improvements were maintained for up to 24 weeks after treatment had finished.
Significant reduction in pain associated with Raynaud attacks.
Treatment was well tolerated with no significant device-related adverse events.

Clinical Relevance

This study demonstrates that auricular electrical stimulation can significantly reduce the frequency and severity of symptoms in patients with primary Raynaud's phenomenon. While objective measures of skin perfusion did not improve, the findings support the role of auricular neuromodulation in regulating autonomic function and reducing vasospastic symptoms, reinforcing its potential value in vascular disorders involving autonomic imbalance.

View Published Paper

Auricular Vagal Nerve Stimulation in Peripheral Arterial Disease

Clinical Question

Can auricular vagus nerve stimulation improve walking ability in patients with intermittent claudication?

Study

Prospective randomised, double-blind, sham-controlled trial involving 40 patients with Fontaine IIb peripheral arterial disease.

Key Findings

60% of treated patients doubled their walking distance.
Significant improvements in walking impairment and quality of life.
Safe and well tolerated.

Clinical Relevance
This study demonstrates that auricular vagus nerve stimulation can improve walking distance, reduce pain and enhance quality of life in patients with peripheral arterial disease. It provides direct clinical evidence supporting the Ducest Neurostimulator as a non-invasive treatment option for patients with intermittent claudication and reinforces its role in improving lower limb perfusion and functional recovery.

View Published Paper

Transcutaneous Stimulation of the Auricular Branch of the Vagus Nerve Attenuates the Acute Inflammatory Response After Lung Lobectomy

Clinical Question

Can transcutaneous auricular vagus nerve stimulation reduce the inflammatory response and improve clinical outcomes following major thoracic surgery?

Study

A randomised clinical study of 100 patients undergoing lung lobectomy via thoracotomy. Patients received transcutaneous auricular vagus nerve stimulation using the Ducest Neurostimulator, beginning 24 hours before surgery and continuing until postoperative day four. Outcomes were compared with a control group receiving standard care.

Key Findings

Reduced inflammatory response, with significantly lower CRP and IL-6 levels on the first postoperative day.
Increased IL-10, indicating enhanced regulation of the postoperative inflammatory response.
Lower incidence of postoperative pneumonia compared with the control group.
Shorter hospital stay, suggesting faster postoperative recovery.

Clinical Relevance

This study demonstrates that auricular vagus nerve stimulation can regulate the body's inflammatory response through activation of the cholinergic anti-inflammatory pathway. Although conducted in thoracic surgery rather than vascular disease, it provides strong clinical evidence supporting one of the Ducest Neurostimulator's key mechanisms of action and its potential to improve recovery by reducing excessive inflammation.

View Published Paper

The Short- and Long-Term Benefit in Chronic Low Back Pain Through Adjuvant Electrical Versus Manual Auricular Acupuncture

Clinical Question

Does electrical auricular stimulation provide greater pain relief and functional improvement than manual auricular acupuncture in patients with chronic low back pain?

Study

A randomised controlled clinical study comparing electrical auricular stimulation with conventional manual auricular acupuncture in patients with chronic low back pain. Participants were assessed for both immediate and longer-term improvements in pain and functional outcomes.

Key Findings

Electrical auricular stimulation produced greater pain relief than manual auricular acupuncture.
Patients experienced significant improvements in functional ability.
Clinical benefits were maintained beyond the treatment period.
Treatment was safe, well tolerated and associated with minimal adverse effects.

Clinical Relevance

This study demonstrates that electrical auricular stimulation can provide meaningful improvements in chronic musculoskeletal pain and functional recovery. It supports the use of auricular neurostimulation as a non-invasive treatment option for chronic pain management and extends the evidence base beyond vascular disease into one of the most common conditions encountered by pain specialists, physiotherapists and rehabilitation clinicians.

View Published Paper

Transcutaneous Auricular Vagus Nerve Stimulation Can Reverse the Manifestations of Long COVID Syndrome: A Pilot Study

Clinical Question

Can transcutaneous auricular vagus nerve stimulation improve symptoms in patients with Long COVID syndrome?

Study

A prospective pilot study involving 20 adults with persistent Long COVID symptoms. Participants received 10 consecutive daily sessions of transcutaneous auricular vagus nerve stimulation and were assessed for changes in fatigue, symptom severity, cognitive function, grip strength and oxygen saturation.

Key Findings

Significant reduction in overall Long COVID symptom severity.
Marked improvement in fatigue, cognitive symptoms and pain.
Significant improvements in grip strength and oxygen saturation.
Treatment was safe, well tolerated and associated with only minor transient side effects.

Clinical Relevance

This pilot study demonstrates the potential of auricular vagus nerve stimulation to improve symptoms associated with Long COVID, particularly where autonomic dysfunction is believed to play a central role. The findings suggest that neurostimulation may help restore autonomic balance, extending the clinical applications of auricular vagus nerve stimulation beyond vascular disease and chronic pain into post-viral syndromes and dysautonomia.

View Published Paper

Clinical Posters & Conference Presentations

Neurostimulation for Chronic Peripheral Arterial Disease When Revascularisation Is Not an Option

Clinical Focus

Can auricular neurostimulation improve symptoms and lower limb perfusion in patients with chronic peripheral arterial disease when conventional treatment options have been exhausted?

Clinical Experience

This clinical case series from Manchester University NHS Foundation Trust reports outcomes in five patients with chronic symptomatic peripheral arterial disease who were unsuitable for further revascularisation. All patients were treated with the Ducest Neurostimulator and underwent objective vascular assessment before and after treatment.

Key Outcomes

Clinically meaningful improvement in walking distance in all five patients.
Significant reduction in claudication pain, with two patients becoming pain-free.
Marked increases in tibial arterial blood flow demonstrated by duplex ultrasound.
Improvements in arterial diameter and Doppler waveforms following treatment.
All patients reported meaningful symptomatic improvement following treatment.

Clinical Relevance

This case series demonstrates how auricular neurostimulation is being used in NHS clinical practice for patients with advanced peripheral arterial disease who have limited treatment options. The combination of symptomatic improvement and objective vascular measurements provides encouraging real-world evidence supporting its role as a non-invasive therapeutic option.

Publication Details

Title: Neurostimulation for Chronic Peripheral Arterial Disease When Revascularisation Is Not an Option

Authors: A. Singhania, A. Quddus

Journal: British Journal of Surgery (Supplement)

Year: 2022

DOI: 10.1093/bjs/znac269.532

PMID: Not available

Neurostimulation for Severe Peripheral Arterial Disease When No Further Revascularisation Is Possible

Clinical Focus

Can auricular neurostimulation improve symptoms, circulation and limb salvage in patients with end-stage peripheral arterial disease who have no remaining revascularisation options?

Clinical Experience

This NHS pilot study from Manchester University NHS Foundation Trust evaluated 13 patients with end-stage peripheral arterial disease who had exhausted conventional treatment options. Patients received treatment with the Ducest Neurostimulator and underwent clinical assessment together with objective vascular measurements before and after treatment.

Key Outcomes

Improved walking distance in 9 of the 13 patients.
Reduction in pain and improved quality of life in 11 patients.
Reduced rest pain and lower analgesic requirements in 8 patients.
Objective improvements in tibial blood flow, vessel diameter, ankle pressure and toe pressure in the majority of patients.
Major limb amputation was avoided in 5 patients, with one additional amputation delayed by five months.

Clinical Relevance

This NHS pilot study provides encouraging real-world evidence that auricular neurostimulation may improve peripheral circulation and quality of life in patients with advanced peripheral arterial disease who have no further surgical or endovascular treatment options. The combination of symptomatic improvement and objective vascular measurements supports its potential role as an adjunctive therapy in carefully selected patients.

Neurostimulation for Chronic Peripheral Arterial Disease

Clinical Question

Can auricular neurostimulation improve symptoms and lower limb blood flow in patients with chronic peripheral arterial disease who are unsuitable for further revascularisation?

Study

Prospective NHS case series involving five patients with chronic symptomatic peripheral arterial disease who had exhausted conventional treatment options.

Key Findings

Walking distance improved in all patients.
Significant reductions in ischaemic pain, with two patients becoming pain free.
Duplex ultrasound demonstrated increased arterial blood flow.
All patients experienced clinically meaningful symptomatic improvement.

Publication Details

Title: Neurostimulation – A Promising Treatment Option for Chronic Peripheral Arterial Disease When Revascularisation and Conservative Management Are Unsuitable

Authors: A. Singhania, A. Quddus

Publication: Case Series Poster, Manchester University NHS Foundation Trust

Year: 2024 (the document itself doesn't state a year, so use the actual poster year if you know it; otherwise omit it)

DOI: None

PMID: None

View Published Poster

Turn Clinical Evidence into Better Patient Outcomes

Whether you're exploring auricular neurostimulation for vascular disease, chronic pain, rehabilitation or emerging clinical applications, we're here to help.

Discuss the evidence, arrange a product demonstration or explore how the Ducest Neurostimulator could support your clinical practice.

Contact Stopford Surgical

Evidence. Recovery. Performance